Single-dose Prophylactic INdomethacin in Extremely Preterm Infants

Clinical trial NCT06572917 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06572917
Sponsor: University of British Columbia
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extreme Prematurity Intraventricular Hemorrhage Morbidity;Newborn

Start date: 2025-11-01
Primary completion: 2028-12-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.